Fmoc-L-aspartic acid β-tert.buty ester is a protected L-aspartic acid derivative in which the α-amino group is masked by an Fmoc (9-fluorenylmethoxycarbonyl) carbamate and the β-carboxyl group is esterified as a tert-butyl ester. The molecule contains an Fmoc-protected amine, a tert-butyl-protected side-chain carboxyl group, and the remaining α-carboxyl functionality is present as part of the aspartic acid backbone, providing chemoselectivity by suppressing side-chain carboxyl reactivity during peptide coupling. In solid-phase peptide synthesis and related stepwise assembly workflows, it is employed as a building block that enables controlled incorporation of an aspartate side chain while the protecting groups help prevent undesired acylation or salt formation from the unprotected functional groups.
Fmoc-L-aspartic acid β-tert.buty ester is an Fmoc-protected L-aspartate derivative in which the α-amino group is masked as an Fmoc carbamate and the side-chain carboxyl is esterified as a tert-butyl ester, preserving the stereogenic L-configuration at the α-carbon. The molecule contains a protected amine for controlled peptide coupling, a base-stable tert-butyl ester that can be selectively removed under acidic conditions, and an Fmoc group that can be cleaved to reveal the free amine for stepwise solid-phase or solution-phase synthesis. The aspartate side chain provides a carboxyl functional handle that can be converted into amides, esters, or activated acids after deprotection, enabling downstream functionalization and incorporation into acidic peptide motifs. The combination of orthogonal protecting-group chemistry and an amino-acid-compatible scaffold makes the compound suitable as a chiral intermediate for peptide building block preparation and for manufacturing routes that require predictable protection/deprotection behavior.
1. Peptide Synthesis
Fmoc-L-aspartic acid β-tert.buty ester is applied in peptide synthesis workflows where Fmoc removal generates a reactive α-amino group for peptide coupling while the β-tert-butyl ester remains protected during chain assembly. The aspartate side-chain carboxyl, protected as a tert-butyl ester, supports sequential orthogonal deprotection strategies that allow β-carboxyl activation after the peptide backbone is formed. The preserved L-stereochemistry at the α-center supports stereochemically consistent incorporation into peptide sequences and aspartate-containing motifs. Downstream, the β-carboxyl can be converted into amide or activated acid forms for introducing side-chain modifications, enabling controlled generation of aspartyl residues in peptides and peptidomimetic scaffolds.
2. Side-Chain Functionalization
Fmoc-L-aspartic acid β-tert.buty ester serves as a side-chain functionalization intermediate for building libraries of aspartate derivatives used in chemical biology and SAR studies. The β-tert-butyl ester protection allows the side-chain carboxyl to be carried through coupling steps without premature reactivity, while later deprotection can reveal a free carboxyl group for derivatization. The resulting β-carboxyl can be transformed into amides, esters, or mixed anhydrides to install linkers, affinity handles, or charge-modulating substituents on peptide analogs. The orthogonal protection pattern also supports selective modification of the aspartate side chain while maintaining compatibility with Fmoc-based assembly logic.
3. Protected Amino Acids
Fmoc-L-aspartic acid β-tert.buty ester is utilized as a protected amino acid building block in protected amino acid chemistry and chiral intermediate preparation for peptide-grade synthesis. The Fmoc carbamate provides an amine-protection strategy that withstands typical coupling conditions and can be removed to expose the nucleophilic amine for subsequent acylation. The β-tert-butyl ester functions as a protecting group for the side-chain carboxyl, enabling controlled deprotection to access a reactive acid functionality for later activation or conjugation. The stereochemical integrity of the L-aspartate framework supports reproducible incorporation into synthetic sequences, including manufacturing-oriented production of defined peptide intermediates and fine chemical targets.
4. Bioconjugation Chemistry
Fmoc-L-aspartic acid β-tert.buty ester can be incorporated into bioconjugation strategies where aspartate-containing peptide segments act as chemically addressable scaffolds for linker installation. The protected β-carboxyl group can be deprotected to generate a carboxylate suitable for coupling reactions that form amide bonds with amine-bearing biomolecule conjugates or for activation-based attachment of reporter or affinity moieties. The Fmoc-protected amine supports controlled assembly of conjugatable peptide fragments, reducing side reactions during intermediate handling. The resulting aspartate-functionalized conjugation precursors can be used to generate biomolecule-modified constructs, including labeled peptides and protein-binding ligands, while maintaining stereochemical fidelity at the amino acid center.
5. Pharmaceutical Manufacturing
Fmoc-L-aspartic acid β-tert.buty ester is relevant to pharmaceutical manufacturing and process chemistry as a defined, protected amino acid intermediate for producing aspartate-containing peptide intermediates under controlled protection-group logic. The orthogonal Fmoc/tert-butyl ester protection enables stepwise processing in which amine deprotection and side-chain carboxyl deprotection can be sequenced to match manufacturing workflow constraints. The stable protected groups during peptide assembly support reproducible material handling, while the later availability of the β-carboxyl supports conversion into activated forms for downstream coupling to generate drug-relevant peptide components. The compound's chiral amino acid structure and predictable functional group reactivity make it suitable for scalable fine chemical synthesis of peptide building blocks and controlled intermediate generation for industrial peptide manufacture.
6. Analytical Research
Fmoc-L-aspartic acid β-tert.buty ester is used in analytical research settings as a reference material and derivatization precursor for monitoring amino acid incorporation, protecting-group behavior, and peptide coupling outcomes. The combination of Fmoc and tert-butyl ester functionalities provides distinct chemical signatures that can be exploited in chromatographic and spectrometric workflows to track deprotection events and confirm structural integrity of aspartate-containing intermediates. The L-aspartate stereochemistry supports method development for stereochemically sensitive analyses and for verifying that synthetic sequences preserve the intended configuration at the α-carbon. The compound's well-defined protected functional groups also make it suitable for preparing standards and internal controls used to evaluate peptide building block quality and intermediate consistency in applied peptide science.
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More